Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Institut de Cancérologie de Lorraine100 enrolled

Overview

The aim is to identify in patients with brain metastases the predictive factors of overall survival, survival without local recurrence and survival with progression-free brain metastases after complementary whole brain radiotherapy.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Brain Metastasis

Interventions

whole brain radiotherapyRADIATION

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with one to three brain metastases treated in our department with hypofractionated stereotactic radiotherapy (SRT) from March 2008 to February 2013. Exclusion Criteria: * A patient record captured after February 2013.

Locations (1)

Institut de Cancerologie de Lorraine

Vandœuvre-lès-Nancy, France

Outcomes

Primary Outcomes

Overall survival

Time frame: 72 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.